Editorial overview: Tumour immunology: Engineered T cell therapy of cancer: current success and future improvements.

Curr Opin Immunol

UCL Institute of Immunity & Transplantation, Division of Infection & Immunity, Pears Building̥, London NW3 2PP, United Kingdom. Electronic address:

Published: June 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2022.102175DOI Listing

Publication Analysis

Top Keywords

editorial overview
4
overview tumour
4
tumour immunology
4
immunology engineered
4
engineered cell
4
cell therapy
4
therapy cancer
4
cancer current
4
current success
4
success future
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!